We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
451
Pfizer
PFE
$144B
$683K 0.08%
23,599
+389
+2% +$11.3K
CAE icon
452
CAE Inc. Common Shares
CAE
$8.45B
$678K 0.08%
36,143
+14,981
+71% +$268K
SSTK icon
453
Shutterstock
SSTK
$220M
$673K 0.08%
+19,038
New +$702K
NSSC icon
454
Napco Security Technologies
NSSC
$1.33B
$672K 0.08%
+16,619
New +$815K
RAMP icon
455
LiveRamp
RAMP
$2.3B
$672K 0.08%
+27,120
New +$740K
CVLT icon
456
Commault Systems
CVLT
$5.15B
$670K 0.08%
+4,355
New +$613K
MDT icon
457
Medtronic
MDT
$111B
$669K 0.08%
7,436
-25,721
-78% -$2.16M
ATR icon
458
AptarGroup
ATR
$8.75B
$667K 0.08%
4,161
-9,648
-70% -$1.43M
GTN icon
459
Gray Television
GTN
$434M
$664K 0.08%
123,870
+78,313
+172% +$403K
UGI icon
460
UGI
UGI
$7.98B
$664K 0.08%
26,525
-24,065
-48% -$580K
MERC icon
461
Mercer International
MERC
$46.6M
$662K 0.08%
+97,834
New +$677K
ZUO
462
DELISTED
Zuora, Inc.
ZUO
$662K 0.08%
76,763
+60,501
+372% +$537K
ICFI icon
463
ICF International
ICFI
$1.5B
$654K 0.08%
3,921
-869
-18% -$134K
EEFT icon
464
Euronet Worldwide
EEFT
$3.14B
$653K 0.08%
+6,580
New +$666K
TRNS icon
465
Transcat
TRNS
$807M
$652K 0.08%
5,396
+3,137
+139% +$390K
TK icon
466
Teekay
TK
$981M
$651K 0.08%
70,799
-5,561
-7% -$46.2K
UPBD icon
467
Upbound Group
UPBD
$1.26B
$651K 0.08%
+20,360
New +$654K
DAL icon
468
Delta Air Lines
DAL
$58.7B
$649K 0.08%
+12,772
New +$557K
PUBM icon
469
PubMatic
PUBM
$609M
$647K 0.08%
43,541
+26,768
+160% +$465K
GDDY icon
470
GoDaddy
GDDY
$13.5B
$647K 0.08%
+4,129
New +$631K
ESTC icon
471
Elastic
ESTC
$6.51B
$647K 0.08%
8,425
+5,271
+167% +$520K
HOG icon
472
Harley-Davidson
HOG
$2.69B
$642K 0.08%
+16,671
New +$604K
HPP
473
Hudson Pacific Properties
HPP
$782M
$640K 0.08%
19,120
+3,326
+21% +$120K
WMS icon
474
Advanced Drainage Systems
WMS
$11.1B
$636K 0.08%
4,048
-3,217
-44% -$502K
PTVE
475
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$630K 0.08%
54,692
+15,385
+39% +$177K
17 18
19
20 21

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.